Corvus Pharmaceuticals, Inc. (CRVS) Earnings
NASDAQ·Healthcare·Biotechnology
$13.90
+3.96%
Mkt Cap $1.11B
EPS — Estimate vs Actual
Mkt Cap
$1.11B
P/E
—
Fwd P/E
—
P/S
—
Rev TTM
—
EPS TTM
-$0.55
NASDAQ·Healthcare·Biotechnology
$13.90
+3.96%
Mkt Cap $1.11B
Mkt Cap
$1.11B
P/E
—
Fwd P/E
—
P/S
—
Rev TTM
—
EPS TTM
-$0.55